Home Report Store Saudi Arabia Next Generation Sequencing (NGS) Market

Saudi Arabia Next Generation Sequencing (NGS) Market Size, Share, Forecast, & Trends Analysis by Offering (Sample Preparation (DNA Extraction, Library Preparation), Instruments) Type (SMRT, DNB) Application (Clinical, Research) End User – Forecast to 2031

Report ID:MRHC - 1041319 Pages: 183 Sep-2024 Formats*: PDF Category: Healthcare Delivery: 2 to 4 Hours

The Saudi Arabia NGS Market was valued at $ 24.4 million in 2023. This market is anticipated to reach $50 million by 2031 from an estimated $ 25.5 million in 2024, at a CAGR of 10.1% during the forecast period from 2024 to 2031.

Saudi Arabia NGS Market Size & Forecast

Key factors driving the growth of this market include the rise in cancer incidence, the increasing application of NGS in cancer treatment and research, and technological advancements in NGS. Furthermore, the rising adoption of genomic data management solutions and collaborations between vendors to develop library preparation protocols are expected to create market growth opportunities.

Saudi Arabia NGS Market Growth Drivers

Rising Cancer Prevalence & Increasing Application of NGS in Cancer Treatment

Cancer is a leading cause of death and a significant barrier to improving life expectancy in Saudi Arabia. Furthermore, according to GLOBOCAN, cancer incidence in Saudi Arabia is projected to reach 39,900 cases by 2030, an increase from 28,113 cases in 2022. Similarly, cancer-related mortalities are expected to increase from 13,400 in 2022 to 42,100 in 2045. This rising prevalence is anticipated to drive the adoption of NGS in clinical settings. NGS has significantly advanced researchers' understanding of cancer biology by revealing genetic heterogeneity even among cancer types previously thought to be identical. The identification of unique molecular signatures is facilitating the development of potential cancer treatments and driving the demand for NGS in cancer research. The applications of NGS in oncology research include basic drug discovery, translational research, patient testing, and clinical trials. Specifically, NGS is used for diagnostic and prognostic studies, monitoring drug resistance, biomarker identification, therapy selection, and tumor classification.

Saudi Arabia Next Generation Sequencing (NGS) Market Click here to: Get Free Sample Pages of this Report

Increasing Use of NGS in Clinical Applications

NGS technology has revolutionized genetic disease diagnostics with rapid, high-throughput, and cost-effective approaches. NGS technology can simultaneously analyze hundreds of genes, the whole exome, and even the whole genome, enabling researchers to gain a deeper understanding of the genetic heterogeneity of rare diseases. NGS has great potential to enhance cancer diagnosis and care. Using NGS technology, various genomic aberrations, such as common and rare variants, structural variations (e.g., insertions and deletions), copy-number variations, and fusion transcripts, can be screened simultaneously.

NGS has gained significance in clinical practices for oncology, reproductive health, Mendelian disorders, complex diseases, and infectious diseases. In the coming years, NGS is expected to diversify in other clinical areas, with a considerable reduction in sequencing costs. The technology is expected to show substantial penetration in applications such as liquid biopsies for the early detection and monitoring of cancer and reproductive health applications. New biomarkers and actionable mutations are being identified by researchers, which are consequently expected to increase the applications and usage of NGS technology, creating growth opportunities for the players operating in the NGS market.

Saudi Arabia NGS Market Opportunity

Increasing Application of NGS in Personalized Medicine

Precision medicine is an emerging approach to patient care that customizes treatment based on an individual's genetic makeup, considering genetic changes due to disease, lifestyle factors, and environmental influences. This approach aims to move beyond the trial-and-error method of medication by providing targeted treatments based on each patient’s unique genetic profile. Precision medicine can address variability in diagnostic capabilities and aid in developing treatment strategies tailored to specific genetic and demographic characteristics. Advancements in NGS technology are transforming how doctors diagnose and treat diseases. The field of targeted treatments, which utilizes genomic data to tailor patient-specific therapies, is rapidly advancing and has increasingly become part of mainstream clinical practice. This approach involves the molecular profiling of cells to identify targetable genetic alterations, also known as biomarkers. NGS technology enables the rapid and reliable sequencing of multiple genes simultaneously. This capability has significantly contributed to the development of precision medicine, which involves customizing treatments based on specific molecular changes associated with an individual's disease.

Saudi Arabia NGS Market Trend

Development of Portable Sequencing Technologies

The development of portable handheld sequencing devices has made sequencing more affordable, simpler, and faster without requiring large clinical laboratory settings. Real-time sequencing allows researchers and physicians to quickly access and act on sequencing data. Portable nanopore-based sequencers can sequence entire genomes for less than USD 1,000. These devices work by passing DNA molecules through a nanopore, which is a small protein embedded in a membrane. As the DNA molecule moves through the nanopore, it interacts with the adaptor, creating a change in electric current. This current change is recorded and often visualized as a graph. Real-time sequencing is increasingly being adopted for various applications, including disease characterization, contaminant detection, and plant genome analysis. For instance, King Abdulaziz University in Jeddah, Saudi Arabia, funded a research study on the genotyping of the Rh Blood Group D antigen using a portable nanopore-based sequencing device.

Saudi Arabia NGS Market Analysis: Key Findings

In 2024, the Consumables Segment to Dominate the Market

By offering, the Saudi Arabia NGS market is segmented into consumables, NGS platforms/instruments, software, and services. In 2024, the consumables segment is expected to account for the largest share of 62.6% of the Saudi Arabia NGS market. This segment is projected to reach $31.8 million by 2031 from an estimated $16.0 million in 2024, at a CAGR of 10.3% during the forecast period. Ongoing advancements in reagents, kits, and target enrichment protocols, coupled with the high adoption of sequencing in healthcare facilities, are driving the demand for consumables used in NGS. The frequent use of these consumables, coupled with a growing demand for NGS-based diagnostic tests and applications in oncology, reproductive health, and drug discovery, contribute to the significant share of this market segment.

In 2024, the Targeted Genome Sequencing Segment to Dominate the Market

By sequencing type, the Saudi Arabia NGS market is segmented into targeted genome sequencing, whole genome sequencing, whole exome sequencing, and other sequencing types. In 2024, the targeted genome sequencing segment is expected to account for the largest share of the Saudi Arabia NGS market. This segment's significant market share is attributed to the advantages of targeted genome sequencing, such as low cost, quick results, and straightforward data analysis for specific areas of interest. These benefits have led to its widespread adoption in diagnostic applications.

Targeted sequencing is useful for identifying somatic mutations in complex samples such as cancerous tumors mixed with germline DNA, hence used in investigating the genetic causes of cancer and other disorders. Thus, the rising use of targeted genome sequencing in the diagnosis is further contributing to the significant market share of this segment.

In 2024, the Research Applications Segment to Dominate the Market

By application, the Saudi Arabia NGS market is segmented into research & other applications and clinical applications. In 2024, the research & other applications segment is expected to account for the largest share of 56.9% of the Saudi Arabia NGS market. This segment is projected to reach $29.3 million by 2031 from an estimated $ 14.5 million in 2024, at a CAGR of 10.6% during the forecast period. The segment's significant market share is due to the rapid adoption of NGS among academic and research institutions, the increasing demand for personalized medicine, and heightened investments by pharmaceutical and biotechnology companies in drug discovery. Additionally, the expanding applications of NGS in oncology, agriculture, and other research areas, along with the advantages of genetic research utilizing NGS technology and the rising incidence of cancer, are contributing to the segment’s significant market share.

In 2024, the Hospitals & Diagnostic Laboratories Segment to the Market

By end user, the Saudi Arabia NGS market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, academic & research centers, and other end users. In 2024, the hospitals & diagnostic laboratories segment is expected to account for the largest share of the Saudi Arabia NGS market. This segment’s significant market share is due to the rising demand for NGS-based diagnostic testing, improvements in healthcare infrastructure, and increasing public-private partnerships within the healthcare sector. Growing investments from both private and public entities to expand hospital capacities are further fueling the demand for NGS assays and instruments in these settings. According to the Centre for Public Policy Research (CPPR) (India), the Saudi Arabian government has invested over USD 65 billion through its Vision 2030 initiative, which supports the restructuring, privatization, and technological advancement of healthcare facilities.

Saudi Arabia NGS Market: Key Companies

The report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios and the key growth strategies adopted by them over the past three to four years. Some of the key players operating in the Saudi Arabia NGS market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Oxford Nanopore Technologies Plc. (U.K.), Beijing Genomics Institute (BGI) (China), Bio-Rad Laboratories, Inc. (U.S.), and 10x Genomics, Inc. (U.S.).

Saudi Arabia NGS Industry Overview: Latest Developments from Key Industry Players

In August 2024, Illumina, Inc. (U.S.) introduced a new oncology menu for customers using the NovaSeq X Series. This includes the launch of a high-throughput version of TruSight Oncology 500 (TSO 500 HT) and the latest iteration of the distributed liquid biopsy research assay, TruSight Oncology 500 ctDNA v2 (TSO 500 ctDNA v2).
In June 2024, Pacific Biosciences of California Inc. (U.S.), in collaboration with the International Consortium for Long-Read Sequencing (CoLoRS), launched a free HiFi long-read variant frequency database. This initiative is designed to assist rare disease researchers by offering access to genetic variants that are not detectable with the short-read sequencing method.
In June 2024, QIAGEN N.V. (Netherlands) launched an updated version of its clinical decision support software, QIAGEN Clinical Insight Interpret (QCI Interpret). This new version improves scalability and performance, specifically designed to meet the needs of high-throughput NGS laboratories.
In July 2023, Thermo Fisher Scientific Inc. (U.S.) launched two new next-generation sequencing-based products, the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit. Both are designed for reproductive health assays and are compatible with the Ion Torrent Genexus Integrated Sequencer.

Saudi Arabia NGS Market Research Summary

Particulars	Details
Number of Pages	183
Format	PDF
Forecast Period	2024–2031
Base Year	2023
CAGR (Value)	10.1%
Market Size (Value)	USD 50.0 million by 2031
Segments Covered	Saudi Arabia NGS Market, by Offering Consumables Sample Preparation Consumables Library Preparation & Target Enrichment DNA Extraction and Amplification Quality Control Other Kits & Reagents Sequencing Consumables NGS Platform/Instruments Sequencing by Synthesis Ion Semiconductor Sequencing DNA Nanoball (DNB) Sequencing Single-molecule Real-time Sequencing & Nanopore Sequencing Software Services (Note: Other kits & reagents include dilution buffers, DNA standards, reagents for DNA cleanup and nucleic acid extraction, and other reagents required to support the NGS sample preparation workflow.) Saudi Arabia NGS Market, by Sequencing Type Targeted Genome Sequencing Whole Genome Sequencing Whole Exome Sequencing Other Sequencing Types (Note: The other sequencing types segment include degradome sequencing, chromatin immunoprecipitation (ChIP) sequencing, and methylation sequencing.) Saudi Arabia NGS Market, by Application Research & Other Applications Cancer Research Agriculture & Animal Research Microbiology & Infectious Disease Research Genetic Diseases Research Cell & Molecular Biology Research Other Applications Clinical Applications Oncology Reproductive Health Infectious Disease Genetic Disorders Other Clinical Applications (Note 1 : Other applications include food microbiology, microbiome analysis in the beverage industry, and environmental studies) (Note 2 : Other clinical applications include the detection of metabolic and immune disorders and foodborne illnesses.) . Saudi Arabia NGS Market, by End User Pharmaceutical & Biotechnology Companies Hospitals & Diagnostic Laboratories Academic Institutes & Research Centers Other End Users (Note: Other end users include forensic laboratories & security agencies, food & beverage companies, and agriculture companies.)
Countries Covered	Saudi Arabia
Key Companies	Some of the key players operating in Saudi Arabia NGS market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Oxford Nanopore Technologies Plc. (U.K.), Beijing Genomics Institute (BGI) (China), Bio-Rad Laboratories, Inc. (U.S.), and 10x Genomics, Inc. (U.S.).

Key questions answered in saudi arabia NGS market report:

What is the focus of the Saudi Arabia NGS market study?

Next-generation sequencing (NGS) is a method used to determine the nucleotide sequence of DNA or RNA. By providing a detailed nucleotide sequence, NGS offers the most comprehensive understanding of a gene or genome. This sequence serves as a blueprint, containing critical information for constructing an organism, and is essential for a complete understanding of genetic function and evolution.

This study provides valuable insights, market sizes, and forecasts in terms of value by offering, sequencing type, application, and end user.

What is the size of the Saudi Arabia NGS market, and at what CAGR is this market projected to grow during 2024–2031?

The Saudi Arabia NGS market is projected to reach $ 50.0 million by 2031, at a CAGR of 10.1% during the forecast period.

Which offering category is expected to hold the major share of the market in 2024?

In 2024, the consumables segment is expected to account for the largest share of 62.6% of the Saudi Arabia NGS market. This segment is projected to reach $31.8 million by 2031 from an estimated $16.0 million in 2024, at a CAGR of 10.3% during the forecast period. The frequent use of these consumables, coupled with a growing demand for NGS-based diagnostic tests and applications in oncology, reproductive health, and drug discovery, contribute to the significant share of this market segment.

Which is the high-growth end user segment of the Saudi Arabia NGS market?

Based on end user, the pharmaceutical & biotechnology companies segment is slated to register the highest CAGR during the forecast period. The expansion of the biotechnology sector in Saudi Arabia is a key factor fueling the segment’s growth. For instance, the Saudi government has introduced a National Biotechnology Strategy designed to promote local bio-manufacturing and decrease dependence on pharmaceutical imports. Consequently, the share of pharmaceutical imports has fallen from 70% in 2019 to 80% in 2023.

What are the key factors supporting the growth of this market? What are the major opportunities for existing market players and new entrants in the Saudi Arabia NGS market?

Key factors driving the growth of this market include the rising cancer prevalence, the increasing application of NGS in cancer treatment and research, and technological advancements in NGS. Furthermore, the rising adoption of genomic data management solutions and collaborations between vendors to develop library preparation protocols are expected to create market growth opportunities.

Who are the key players operating in the Saudi Arabia NGS market?

Some of the key players operating in the NGS market in Saudi Arabia are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Oxford Nanopore Technologies Plc. (U.K.), Beijing Genomics Institute (BGI) (China), Bio-Rad Laboratories, Inc. (U.S.), and 10x Genomics, Inc. (U.S.).

Enquire

Check Discount

Related Tag: Saudi Arabia Next Generation Sequencing (NGS) Market Saudi Arabia NGS Next-generation DNA sequencing Genome Sequencing NGS Technology Saudi Arabia NGS Industry NGS System Sequencing Platform

In Vitro Diagnostics

Healthcare

1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency & Limitation
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process Of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from The Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Market Share Analysis
2.3.3. Growth Forecast Approach
2.4. Assumptions For the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.1.1. Rising Cancer Prevalence & Increasing Application of NGS in Cancer Treatment and Research Driving Market Growth
4.2.1.2. Availability of Alternative Technologies Restraining Market Growth
4.2.1.3. Increasing Application of NGS In Personalized Medicine Generating Growth Opportunities for Market Players
4.2.1.4. Data Storage, Handling, Interpretation, and Confidentiality Concerns Expected to Remain a Major Challenge for Market Stakeholders
4.2.2. Macroindicators
4.3. Industry Trends
4.3.1. Development of Portable Sequencing Technologies
4.3.2. Increasing Demand for NGS Automation
4.4. Regulatory Analysis
4.5. Health Sector Scenario
4.5.1. Overview
4.5.2. Key Health Indicators
4.5.3. Major Stakeholders
4.5.4. Initiatives/Programs to Improve Healthcare Sector in Saudi Arabia
4.5.4.1. Saudi Vision 2030
4.5.4.2. National Biotech Strategy
4.5.4.3. Saudi Genome Program
4.5.4.4. Healthcare Sector Transformation Program
4.5.4.5. Saudi Biobank Project
4.5.4.6. Saudi Arabia: Regional Headquarters Program (RHQ)
4.5.4.7. Other Large-Scale Initiatives
4.6. IVD Industry Landscape
4.7. Reimbursement Scenario
5. Saudi Arabia Next Generation Sequencing (NGS) Market Assessment—By Offering
5.1. Overview
5.2. Consumables
5.2.1. Sample Preparation Consumables
5.2.1.1. Library Preparation & Target Enrichment
5.2.1.2. DNA Extraction and Amplification
5.2.1.3. Quality Control
5.2.1.4. Other Kits & Reagents
5.2.2. Sequencing Consumables
5.3. NGS Platforms/Instruments
5.3.1. Sequencing By Synthesis
5.3.2. Ion Semiconductor Sequencing
5.3.3. DNA Nanoball (DNB) Sequencing
5.3.4. Single-Molecule Real-Time Sequencing & Nanopore Sequencing
5.4. Software
5.5. Services
6. Saudi Arabia Next-Generation Sequencing Market Assessment—By Sequencing Type
6.1. Overview
6.2. Targeted Genome Sequencing
6.3. Whole Genome Sequencing
6.4. Whole Exome Sequencing
6.5. Other Sequencing Types
7. Saudi Arabia Next-Generation Sequencing Market Assessment—By Application
7.1. Overview
7.2. Research & Other Applications
7.2.1. Cancer Research
7.2.2. Agriculture & Animal Research
7.2.3. Microbiology & Infectious Disease Research
7.2.4. Genetic Diseases Research
7.2.5. Cell & Molecular Biology Research
7.2.6. Other Applications
7.3. Clinical Applications
7.3.1. Oncology
7.3.2. Reproductive Health
7.3.3. Infectious Diseases
7.3.4. Genetic Disorders
7.3.5. Other Clinical Applications
8. Saudi Arabia Next-Generation Sequencing Market Assessment—By End User
8.1. Overview
8.2. Hospitals & Diagnostic Laboratories
8.3. Pharmaceutical & Biotechnology Companies
8.4. Academic & Research Centers
8.5. Other End Users
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis
9.5.1. Illumina, Inc. (U.S.)
9.5.2. F. Hoffmann-La Roche Ltd. (Switzerland)
9.5.3. Beijing Genomics Institute (BGI) (China)
10. Company Profiles
10.1. Illumina, Inc.
10.2. Thermo Fisher Scientific Inc.
10.3. F. Hoffmann-La Roche Ltd
10.4. Beijing Genomics Institute (BGI)
10.5. Pacific Biosciences of California Inc.
10.6. Qiagen N.V.
10.7. Agilent Technologies, Inc.
10.8. Revvity, Inc.
10.9. Danaher Corporation
10.10. Oxford Nanopore Technologies Plc.
10.11. Bio-Rad Laboratories, Inc.
10.12. 10x Genomics, Inc.

List of Tables
Table 1    Saudi Arabia NGS Market: Impact Analysis of Market Dynamics (2024–2031)
Table 2    Saudi Arabia: Estimated Number of New Cancer Cases, by Type (2022 Vs. 2030)
Table 3    Portable Sequencers Vs. Benchtop Sequencers
Table 4    Number of Physicians in Saudi Arabia, 2016-2021 (Per 1000 People)
Table 5    Number of Hospital Beds in Key Government Hospitals
Table 6    Recent Developments
Table 7    Saudi Arabia: Number of Healthcare Providers, by Sector (2023)
Table 8    Saudi Arabia: Healthcare Infrastructure, by Healthcare Provider Type (2023)
Table 9    Prevalence of Common Chronic Diseases in Saudi Arabia Vs. Global (%)
Table 10   Saudi Arabia: Estimated Number of New Cancer Cases, by Type (2022 Vs. 2030)
Table 11   Saudi Arabia: Diabetes Prevalence, 2011 Vs. 2021 Vs. 2030 Vs. 2045
Table 12   Key Government Stakeholders
Table 13   Other Stakeholders
Table 14   Major Focus Areas of Vision 2030 Policy
Table 15   Major Focus Areas of National Biotech Strategy
Table 16   Developments in Saudi Arabia's Regional Headquarters Program
Table 17   Mandatory and Optional Activities for RHQ'S
Table 18   Saudi Arabia NGS Market, by Offering, 2022–2031 (USD Million)
Table 19   Saudi Arabia NGS Consumables Market, by Type, 2022–2031 (USD Million)
Table 20   Saudi Arabia NGS Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 21   Saudi Arabia NGS Platforms/Instruments Market, by Technology, 2022-2031 (USD Million)
Table 22   Major Applications of Ion Torrent Sequencing
Table 23   Saudi Arabia NGS Market, by Sequencing Type, 2022-2031 (USD Million)
Table 24   Saudi Arabia NGS Market, by Application, 2022-2031 (USD Million)
Table 25   Saudi Arabia NGS Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 26   Saudi Arabia NGS Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 27   Currently Available Targeted Therapies and Corresponding Biomarkers
Table 28   Saudi Arabia Next-Generation Sequencing Market, by End User, 2022–2031 (USD Million)
Table 29   Recent Developments, by Company, 2021-2024

List of Figures
Figure 1   Research Process
Figure 2   Secondary Sources Referenced for This Study
Figure 3   Primary Research Techniques
Figure 4   Key Executives Interviewed
Figure 5   Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6   Market Sizing and Growth Forecast Approach
Figure 7   Saudi Arabia NGS Market, by Offering, 2024 Vs. 2031 (USD Million)
Figure 8   Saudi Arabia NGS Market, by Sequencing Type, 2024 Vs. 2031 (USD Million)
Figure 9   Saudi Arabia NGS Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 10   Saudi Arabia NGS Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 11   Saudi Arabia Pharmaceutical Expenditure, 2014 Vs. 2019 Vs. 2024 (USD Billion)
Figure 12   Saudi Arabia: Birth Rate, 2018-2024 (Births Per 1000 People)
Figure 13   Genome Sequencing Costs, 2016-2022 (USD)
Figure 14   Regulatory Process in Saudi Arabia
Figure 15   Saudi Arabia: Healthcare Services Contribution, by Healthcare Provider Type (%)
Figure 16   Distribution of Healthcare Expense Coverage Among Adult Saudi Citizens, By Coverage Type (2023) (% of Total Population)
Figure 17   Distribution of Healthcare Expense Coverage Among Non-Saudi Adult Citizens, by Coverage Type (2023) (% of Total Population)
Figure 18   Number of Hospital Beds in Saudi Arabia, by Healthcare Provider Type (2023)
Figure 19   Distribution of Hospital Beds in Saudi Arabia, by Healthcare Provider Type, 2023 (In %)
Figure 20   Saudi Arabia: Population Structure and Projections, 2023 Vs. 2040 (Million)
Figure 21   Saudi Arabia: Mortality Rate (Death Per 1000 People)
Figure 22   Saudi Arabia: Infant Mortality Rate (Per 1000 Live Births)
Figure 23   Saudi Arabia: Percentage Distribution of Obesity, Overweight, Normal Weight, and Mild Thinness Among Adults (15 Years and Above), by Sex
Figure 24   Saudi Genome Program
Figure 25   Healthcare Sector Transformation Program Targets
Figure 26   Saudi Arabia: IVD Market Size (USD Million)
Figure 27   Saudi Arabia NGS Market, by Offering, 2024 Vs. 2031 (USD Million)
Figure 28   Steps of Sample Preparation in A Typical NGS Workflow
Figure 29   Saudi Arabia Sample Preparation Consumables Market, by Library Preparation & Target Enrichment, 2022–2031 (USD Million)
Figure 30   Saudi Arabia Sample Preparation Consumables Market, by DNA Extraction & Amplification, 2022–2031 (USD Million)
Figure 31   Saudi Arabia Sample Preparation Consumables Market, by Quality Control, 2022–2031 (USD Million)
Figure 32   Saudi Arabia Sample Preparation Consumables Market, by Other Kits & Reagents, 2022–2031 (USD Million)
Figure 33   Saudi Arabia Consumables Market, by Sequencing Consaumbles, 2022–2031 (USD Million)
Figure 34   Saudi Arabia NGS Platforms/Instruments Market, by Sequencing by Synthesis (SBS) Technology, 2022–2031 (USD Million)
Figure 35   Saudi Arabia NGS Platform/Instruments Market, by Ion Semiconductor Sequencing Technology, 2022–2031 (USD Million)
Figure 36   Saudi Arabia NGS Platforms/Instruments Market, by DNA Nanoball (DNB) Sequencing Technology, 2022–2031 (USD Million)
Figure 37   Saudi Arabia: Estimated Number of New Cancer Cases (2022– 2045)
Figure 38   Saudi Arabia NGS Platforms/Instruments Market, by Single-Molecule Real-Time Sequencing & Nanopore Sequencing Technology, 2022–2031 (USD Million)
Figure 39   Saudi Arabia NGS Market, by Software, 2022–2031 (USD Million)
Figure 40   Saudi Arabia NGS Market, by Services, 2022–2031 (USD Million)
Figure 41   Saudi Arabia NGS Market, by Sequencing Type, 2024 Vs. 2031 (USD Million)
Figure 42   Saudi Arabia NGS Market, by Targeted Genome Sequencing, 2022–2031 (USD Million)
Figure 43   Saudi Arabia NGS Market, by Whole Genome Sequencing, 2022–2031 (USD Million)
Figure 44   Saudi Arabia NGS Market, by Whole Exome Sequencing, 2022–2031 (USD Million)
Figure 45   Saudi Arabia NGS Market, by Other Sequencing Types, 2022–2031 (USD Million)
Figure 46   Saudi Arabia NGS Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 47   Saudi Arabia NGS Market, by Cancer Research, 2022–2031 (USD Million)
Figure 48   Saudi Arabia NGS Market, by Agriculture & Animal Research, 2022–2031 (USD Million)
Figure 49   Saudi Arabia NGS Market, by Microbiology & Infectious Disease Research, 2022–2031 (USD Million)
Figure 50   Saudi Arabia NGS Market, by Genetic Diseases Research, 2022–2031 (USD Million)
Figure 51   Saudi Arabia NGS Market, by Cell & Molecular Biology Research, 2022–2031 (USD Million)
Figure 52   Saudi Arabia NGS Market, by Other Applications, 2022–2031 (USD Million)
Figure 53   Estimated Number of New Cancer Cases (2022–2045)
Figure 54   Saudi Arabia NGS Market, by Oncology, 2022–2031 (USD Million)
Figure 55   Saudi Arabia NGS Market, by Reproductive Health, 2022–2031 (USD Million)
Figure 56   Saudi Arabia NGS Market, by Infectious Diseases, 2022–2031 (USD Million)
Figure 57   Saudi Arabia NGS Market, by Genetic Disorders, 2022–2031 (USD Million)
Figure 58   Saudi Arabia NGS Market, by Other Clinical Applications, 2022–2031 (USD Million)
Figure 59   Saudi Arabia NGS Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 60   Saudi Arabia NGS Market, by Hospitals & Diagnostic Laboratories, 2022–2031 (USD Million)
Figure 61   Saudi Arabia NGS Market, by Pharmaceutical & Biotechnology Companies, 2022–2031 (USD Million)
Figure 62   Saudi Arabia NGS Market, by Academic & Research Centers, 2022–2031 (USD Million)
Figure 63   Saudi Arabia NGS Market, by Other End Users, 2022–2031 (USD Million)
Figure 64   Key Growth Strategies Adopted by Leading Players, 2021– 2024
Figure 65   Saudi Arabia Next-Generation Sequencing Market: Competitive Benchmarking, by Offering
Figure 66   Competitive Dashboard: Saudi Arabia Next-Generation Sequencing Market
Figure 67   Saudi Arabia NGS Market Share Analysis, by Key Players (2023)
Figure 68   Illumina, Inc.: Financial Snapshot (2023)
Figure 69   Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
Figure 70   F. Hoffmann-La Roche Ltd.: Financial Snapshot (2023)
Figure 71   Beijing Genomics Institute (BGI): Financial Snapshot (2023)
Figure 72   Pacific Biosciences of California Inc.: Financial Snapshot (2023)
Figure 73   Qiagen N.V: Financial Snapshot (2023)
Figure 74   Agilent Technologies, Inc.: Financial Snapshot (2023)
Figure 75   Revvity, Inc.: Financial Snapshot (2023)
Figure 76   Danaher Corporation: Financial Snapshot (2023)
Figure 77   Oxford Nanopore Technologies Plc.: Financial Snapshot (2023)
Figure 78   Bio-Rad Laboratories, Inc.: Financial Snapshot (2023)
Figure 79   10x Genomics, Inc.: Financial Overview (2023)